← back to search

R. Douglas Bruce

MetroHealth Medical Center · US
Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include HIV, Drug Use, Sexual Risk, HIV/AIDS Research and Interventions, Opioid Use Disorder Treatment, and Noise Effects and Management.
h-index
40
citations
6,075
works
213
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

High burden of tuberculosis infection and disease among people receiving medication-assisted treatment for substance use disorder in Tanzania
PLoS ONE 2021cited by 15position: middledoi
2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV
Clinical Infectious Diseases 2017cited by 90position: firstdoi
2017 HIV Medicine Association of Infectious Diseases Society of America Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With Human Immunodeficiency Virus
Clinical Infectious Diseases 2017cited by 24position: firstdoi
New Hepatitis C Drugs Are Very Costly And Unavailable To Many State Prisoners
Health Affairs 2016cited by 70position: middledoi
An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans
Neuropsychopharmacology 2013cited by 81position: middledoi
A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice
Expert Review of Clinical Pharmacology 2013cited by 47position: firstdoi
Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: A randomized trial
Drug and Alcohol Dependence 2012cited by 121position: middledoi
Impaired Toll-Like Receptor 3-Mediated Immune Responses from Macrophages of Patients Chronically Infected with Hepatitis C Virus
Clinical and Vaccine Immunology 2012cited by 32position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Carla Alexander · University of Maryland, College Park2 papers (2017–2017)— · 2 papers (2012–2013)Maureen Hillhouse · City University of New York2 papers (2012–2013)Kathleen M. Foley · Weill Cornell Medicine2 papers (2017–2017)Paula J. Lum · University of California, San Francisco2 papers (2017–2017)— · 2 papers (2017–2017)Andrew J. Saxon · Seattle University2 papers (2012–2013)Glenn J. Treisman · Johns Hopkins Medicine2 papers (2017–2017)Walter Ling · University of California, Los Angeles2 papers (2012–2013)Jessica S. Merlin · University of Alabama at Birmingham2 papers (2017–2017)— · 2 papers (2017–2017)— · 2 papers (2017–2017)Sébastien Gagneux · Swiss Tropical and Public Health Institute1 papers (2021–2021)Marc N. Gourevitch · New York University1 papers (2013–2013)Klaus Reither · Ludwig-Maximilians-Universität München1 papers (2021–2021)— · 1 papers (2021–2021)— · 1 papers (2012–2012)Christopher R. Bolen · Institute of Infection and Immunity1 papers (2012–2012)— · 1 papers (2013–2013)— · 1 papers (2021–2021)